,i #aahth ,,congress #ast ,session ,h4 ,r4 #ehfd ,,in ,,the ,,house ,,of ,,representatives ,october #b1 #bjbc,mr4 ,fitzpatrick 7for himself and ,ms4 ,clarke of ,new ,york7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend title ,,xix of the ,social ,security ,act to provide for coverage under the ,medicaid program of non-invasive prenatal genetic screening4 #a4 ,short title ,this ,act may be cited as the ,expanded ,genetic ,screening ,act4 #b4 ,medicaid coverage of non-invasive prenatal genetic screening 7a7 ,in general ,section #aije of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;d7 is amended-- 7#a7 in subsection 7a77#c7-- 7,a7 in subparagraph 7,a71 by striking at the end and2 7,b7 in subparagraph 7,b71 by inserting and after the semicolon2 and 7,c7 by adding at the end the following new subparagraph3 7,c7 non-invasive prenatal genetic screening for pregnant women of all age groups 7provided in a facility1 a home1 or other setting71 subject to the informed consent requirement described in subsection 7jj72 2 and 7#b7 by adding at the end the following new subsection3 7jj7 ,informed consent requirement for non-invasive prenatal genetic screening 7#a7 ,in general ,for purposes of subsection 7a77#c77;,c71 the informed consent requirement described in this subsection for non-invasive prenatal genetic screening furnished to a pregnant woman is that1 prior to furnishing the screening to the woman1 the provider of the screening gives the woman a full disclosure that includes1 at a minimum1 the following information3 7,a7 ,the limitations of the screening platform for any genetic screen or test with the goal to identify risk or diagnose a genetic condition4 7,b7 ,any potential interferences that may affect the screening's performance4 7,c7 ,information about predictive values used by the screening based on appropriate matching population and inherent risk factors based on age1 family history1 and other aneuploidy risk factors 7such as ultrasound abnormalities74 7,d7 ,the need for follow-up diagnostic testing to confirm true positive results before decisions are made about irrevocable clinical intervention4 7#b7 ,no medical assistance available for screenings provided without consent ,no payment may be made under section #aijc7;a7 with respect to a non-invasive prenatal genetic screening that is furnished to a pregnant woman without meeting the requirement described in paragraph 7#a74 4 7b7 ,conforming amendment ,section #aijc7;i7 of the ,social ,security ,act 7#db ,u4,s4,c4 #acif;b7i77 is amended-- 7#a7 in paragraph 7#bf71 by striking 2 or2 7#b7 in paragraph 7#bg71 by striking the period and inserting 2 or2 and 7#c7 by inserting after paragraph 7#bg7 the following new paragraph3 7#bh7 with respect to amounts expended for non-invasive prenatal genetic screening services furnished to a pregnant woman1 unless the informed consent requirement of section #aije7;jj7 is met4 4